FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

421155001: Gastro-resistant and prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2614089018 Extended-release enteric coated tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2616689015 Extended-release enteric coated tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
2660661010 Extended-release enteric coated tablet (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
2673148011 Extended release gastro-resistant tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3635961015 Gastro-resistant and prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3635962010 Gastro-resistant and prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gastro-resistant and prolonged-release oral tablet Is a Extended-release tablet false Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Is a Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Is a Prolonged-release oral tablet true Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet Has dose form release characteristic Delayed-release and prolonged-release true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Paroxetine 25mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely domperidone (as domperidone maleate) 30 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely domperidone 30 milligram and omeprazole 20 milligram/1 each gastro-resistant and prolonged-release oral capsule (clinical drug) Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start